Arletta Pharma Solutions
- Biotech or pharma, therapeutic R&D
Arletta Pharma Solutions is a clinical-stage biopharmaceutical company passionate about empowering women to improve their sexual well-being, based in Amsterdam.
Our main asset Lybrido, is a novel treatment for Female Sexual Interest/Arousal Disorder (“FSIAD”) and Hypoactive Sexual Desire Disorder ("HSDD"), affecting > 250 million women. Lybrido is to become the first effective, safe treatment for FSIAD in today’s rapidly growing Women’s Health market.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}